From the development of medical devices to academic offerings and maintenance, we prioritize the well-being of patients. We collaborate with healthcare institutions to provide safe medical technology.

Overview

BTL Industries Ltd was established in 1993 and is a global company based in the United Kingdom. Currently, we have subsidiaries in over 80 countries, and we are a rapidly growing enterprise with approximately 3,750 employees. Our business focuses on the in-house development, manufacturing, and sales of products in three sectors: cosmetic medicine, physiotherapy, and cardiovascular medicine.

German Brand of Medical Devices

Overview

Hermann Müller is a German company specializing in the field of surgical instruments. Through the acquisition of Aygün Surgical Instruments, Hermann Müller has joined forces with a partner that brings more than 35 years of experience in the industry.

Activities and research to reduce medical costs by walking in the local community

Overview

Promotion of walking activities to reduce medical and nursing care costs Support for medical cost analysis and health policy creation in each local government Implementation of health seminars and volunteer training programs in each region Data-based research publication and measurement of health effects

MATRIXOME is a biotech company that develops cell culture matrices for life science research, including those in the stem cell, regenerative medicine and cellular therapy fields.
Our unwavering commitment to innovation is reflected in our unique cell culture substrates which harnesses the power of laminin E8 fragments.

Overview

MATRIXOME is a biotech company that develops cell culture matrices for life science research, including those in the stem cell, regenerative medicine and cellular therapy fields. Our unwavering commitment to innovation is reflected in our unique cell culture substrates which harnesses the power of laminin E8 fragments. The technology behind our surface matrices allows for stronger adhesion with ES/iPS cells than full-length laminin as one of the many advantages. Scientists from all over the world can rely on the quality of our products, with hundreds of publications, as we are the leading provider of human recombinant laminin fragments for ES/iPS cell research in Japan and the world.

NGS and miRNA-based biomarker screening to Cancer-free world by Mirxes

Overview

MiRXES is a biotech company founded by researchers from National University of Singapore. The company was incubated and spun off from Agency of Science Technology and Research (A*STAR) Singapore. The ID3EALTM technology provides high sensitivity and specificity for miRNA detection using qRT-PCR. MiRXES has developed early cancer detection IVD kits and LDT service named GASTROClearTM for gastric cancer and LUNGClearTM for lung cancer with human blood, and spread the products with Fortitude Kit (COVID-19 detection kit) in global market. MiRXES also recently invested in developing Genomics capacity, with NGS devices and bioinformatics team for further R&D project named CADENCE, which aimed to develop the effective and affordable multi-cancer screening test. MiRXES Japan was incorporated in 2020, providing life science solutions such as miRNA and NGS products and services to Japan. MiRXES Japan also continues to establish clinical collaborations for optimization and validation of our cancer early detection for commercialization in Japan.

Overview

Phicell offers R&D support services with a focus on sample storage and management for medical, pharmaceutical and Regenerative medical companies. We manage your precious biosamples in our facility on GMP-compliant grade. You can choose storage temperature among ultralow temperature freezers and cryopreservation containers.
* Phicell is wholly-owned subsidiary of Saroute (Saroute is the logistics company providing the transportation service for the Medical and Pharmaceuticals)